↓ Skip to main content

Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye

Overview of attention for article published in Pharmaceutical Research, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#15 of 2,938)
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
4 news outlets
blogs
1 blog
twitter
4 X users
patent
7 patents

Citations

dimensions_citation
162 Dimensions

Readers on

mendeley
469 Mendeley
Title
Pharmaceutical Development of AAV-Based Gene Therapy Products for the Eye
Published in
Pharmaceutical Research, December 2018
DOI 10.1007/s11095-018-2554-7
Pubmed ID
Authors

Gerard A. Rodrigues, Evgenyi Shalaev, Thomas K. Karami, James Cunningham, Nigel K. H. Slater, Hongwen M. Rivers

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 469 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 469 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 76 16%
Student > Ph. D. Student 63 13%
Student > Master 44 9%
Student > Bachelor 44 9%
Other 35 7%
Other 55 12%
Unknown 152 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 116 25%
Pharmacology, Toxicology and Pharmaceutical Science 34 7%
Medicine and Dentistry 31 7%
Agricultural and Biological Sciences 30 6%
Chemical Engineering 16 3%
Other 74 16%
Unknown 168 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 January 2024.
All research outputs
#814,863
of 24,291,750 outputs
Outputs from Pharmaceutical Research
#15
of 2,938 outputs
Outputs of similar age
#19,416
of 445,092 outputs
Outputs of similar age from Pharmaceutical Research
#2
of 28 outputs
Altmetric has tracked 24,291,750 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,938 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,092 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.